Multi-drug resistance (MDR): Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(2 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
Multi-drug resistance is a condition where cancer cells are resistant to chemotherapy drugs due to the presence on a drug eflux pump called the [[P-glycoprotein|p-glycoprotein]] that actively pumps out drugs from the cell. P-glycoprotein in normal [[ | Multi-drug resistance is a condition where [[Cancer|cancer]] cells are resistant to [[Chemotherapy|chemotherapy]] drugs due to the presence on a drug eflux pump called the [[P-glycoprotein|p-glycoprotein]] that actively pumps out drugs from the cell. [[P-glycoprotein|P-glycoprotein]] in normal gut [[Epithelial cells|epithelial cells]] help to expell toxic substances in the food we eat, but this is up-regulated in [[Cancer|cancer]] cells. The p-[[Glycoprotein|glycoprotein]] is part of the [[ABC transporter superfamily|ABC transporter superfamily]]. Also see [[Antibiotic_resistance|Antibiotic Resistance]]. |
Latest revision as of 13:10, 23 October 2017
Multi-drug resistance is a condition where cancer cells are resistant to chemotherapy drugs due to the presence on a drug eflux pump called the p-glycoprotein that actively pumps out drugs from the cell. P-glycoprotein in normal gut epithelial cells help to expell toxic substances in the food we eat, but this is up-regulated in cancer cells. The p-glycoprotein is part of the ABC transporter superfamily. Also see Antibiotic Resistance.